Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”

Detalles Bibliográficos
Autores principales: Asadollahzade, Elnaz, Ghadiri, Fereshteh, Ebadi, Zahra, Moghadasi, Abdorreza Naser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2022
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779974/
https://www.ncbi.nlm.nih.gov/pubmed/36449809
http://dx.doi.org/10.1590/1806-9282.20221037
_version_ 1784856741579587584
author Asadollahzade, Elnaz
Ghadiri, Fereshteh
Ebadi, Zahra
Moghadasi, Abdorreza Naser
author_facet Asadollahzade, Elnaz
Ghadiri, Fereshteh
Ebadi, Zahra
Moghadasi, Abdorreza Naser
author_sort Asadollahzade, Elnaz
collection PubMed
description
format Online
Article
Text
id pubmed-9779974
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Associação Médica Brasileira
record_format MEDLINE/PubMed
spelling pubmed-97799742022-12-23 Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study” Asadollahzade, Elnaz Ghadiri, Fereshteh Ebadi, Zahra Moghadasi, Abdorreza Naser Rev Assoc Med Bras (1992) Letter to the Editor Associação Médica Brasileira 2022-11-28 /pmc/articles/PMC9779974/ /pubmed/36449809 http://dx.doi.org/10.1590/1806-9282.20221037 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Asadollahzade, Elnaz
Ghadiri, Fereshteh
Ebadi, Zahra
Moghadasi, Abdorreza Naser
Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
title Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
title_full Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
title_fullStr Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
title_full_unstemmed Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
title_short Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
title_sort comment on “alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9779974/
https://www.ncbi.nlm.nih.gov/pubmed/36449809
http://dx.doi.org/10.1590/1806-9282.20221037
work_keys_str_mv AT asadollahzadeelnaz commentonalemtuzumabimprovescognitiveprocessingspeedinactivemultiplesclerosisalongitudinalobservationalstudy
AT ghadirifereshteh commentonalemtuzumabimprovescognitiveprocessingspeedinactivemultiplesclerosisalongitudinalobservationalstudy
AT ebadizahra commentonalemtuzumabimprovescognitiveprocessingspeedinactivemultiplesclerosisalongitudinalobservationalstudy
AT moghadasiabdorrezanaser commentonalemtuzumabimprovescognitiveprocessingspeedinactivemultiplesclerosisalongitudinalobservationalstudy

Ejemplares similares